Stock

Caris Life Sciences, Inc. CAI

$15.53-0.80%

All stocks Create account to unlock

Overview

CAI market data

Price History

CAI price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for CAI. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

7 captured

Caris Life Sciences To Offer In-House PTEN Immunohistochemistry Testing After Recent FDA Approval Of Biomarker-Guided Therapy And Diagnostic Assay · Jul 14, 2026, 12:36 PM

Caris Life Sciences Announces Dual Listing Of Common Shares On NYSE Texas, Effective June 17 · Jun 16, 2026, 12:40 PM

Caris Life Sciences Announces $100M Buyback Plan · Jun 8, 2026, 12:40 PM

Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows · Jun 4, 2026, 6:15 PM

Wolfe Research Assumes Caris Life Sciences at Peer Perform · Jun 2, 2026, 12:16 PM

Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech · May 18, 2026, 2:15 PM

Caris Life Sciences Announces Publication Of A Caris‑Led Study In The Oncologist The Shows Its Lookback Program's Ability To Identify Previously-Profiled Patients Who Become Eligible For Newly Approved Targeted Therapies · May 15, 2026, 12:40 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock